Literature DB >> 3124170

Noradrenergic and behavioural effects of naloxone injected in the locus coeruleus of morphine-dependent rats and their control by clonidine.

E Esposito1, A Kruszewska, G Ossowska, R Samanin.   

Abstract

Naloxone HCl (10 micrograms/0.5 ml) was injected in the locus coeruleus (LC) of morphine-dependent rats and the behavioural manifestations of morphine withdrawal and the cortical levels of 3-methoxy-4-hydroxyphenylethyleneglycol sulfate (MHPG-SO4) were measured 30 min later. Naloxone precipitated a withdrawal syndrome and raised cortical MHPG-SO4 in animals made dependent by ascending doses of morphine for 11 days. An injection of clonidine intraperitoneally (200 micrograms/kg) or in the LC (5 micrograms/0.5 microliter) blocked most aspects of the withdrawal syndrome except jumping and had no effect on the naloxone-induced rise in cortical MHPG-SO4. The findings confirm the hypothesis that the LC is one of the sites where naloxone and clonidine, respectively, precipitate and reduce the narcotic withdrawal syndrome but argue against a role of noradrenergic neurons originating in the LC and innervating the cortex in the ability of clonidine to suppress some aspects of withdrawal syndrome precipitated by naloxone in morphine-dependent animals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3124170     DOI: 10.1007/bf00187263

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  Effects of clonidine on morphine withdrawal signs in the rat.

Authors:  L F Tseng; H H Loh; E T Wei
Journal:  Eur J Pharmacol       Date:  1975-01       Impact factor: 4.432

2.  Stimulation and destruction of the locus coeruleus: opposite effects on 3-methoxy-4-hydroxyphenylglycol sulfate levels in the rat cerebral cortex.

Authors:  J Korf; G K Aghajanian; R H Roth
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

3.  Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite.

Authors:  S M Schanberg; J J Schildkraut; G R Breese; I J Kopin
Journal:  Biochem Pharmacol       Date:  1968-02       Impact factor: 5.858

4.  Simultaneous determination of noradrenaline and 3-methoxy-4-hydroxyphenylethyleneglycol sulfate in discrete brain regions of the rat.

Authors:  Y Kohno; K Matsuo; M Tanaka; T Furukawa; N Nagasaki
Journal:  Anal Biochem       Date:  1979-09-01       Impact factor: 3.365

5.  Clonidine reverses the increased norepinephrine turnover during morphine withdrawal in rats.

Authors:  R Laverty; R H Roth
Journal:  Brain Res       Date:  1980-01-27       Impact factor: 3.252

6.  Central sites of naloxone-precipitated shaking in the anesthetized, morphine-dependent rat.

Authors:  E Wei; S S Sigel; H H Loh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1975-12       Impact factor: 4.030

7.  Lesioning of serotoninergic and noradrenergic nerve fibres of the rat brain does not decrease binding of 3H-clonidine and 3H-rauwolscine to cortical membranes.

Authors:  G Gross; M Göthert; U Glapa; G Engel; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

8.  Brain catecholamine metabolites and behavior in morphine withdrawal.

Authors:  A C Swann; J D Elsworth; D S Charney; D M Jablons; R H Roth; D E Redmond; J W Maas
Journal:  Eur J Pharmacol       Date:  1982-12-24       Impact factor: 4.432

9.  Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine.

Authors:  K T Britton; T Svensson; J Schwartz; F E Bloom; G F Koob
Journal:  Life Sci       Date:  1984-01-09       Impact factor: 5.037

10.  Sites of action of morphine involved in the development of physical dependence in rats. II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various brain areas.

Authors:  E Laschka; H Teschemacher; P Mehraein; A Herz
Journal:  Psychopharmacologia       Date:  1976-03-16
View more
  6 in total

1.  Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism.

Authors:  F Ruiz; M C Fournié-Zaluski; B P Roques; R Maldonado
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

2.  Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal.

Authors:  R Maldonado; O Valverde; C Garbay; B P Roques
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

3.  Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".

Authors:  E Fdez Espejo; M Cador; L Stinus
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

4.  Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell.

Authors:  Ruth Sharf; Maysa Sarhan; Ralph J Dileone
Journal:  Biol Psychiatry       Date:  2008-04-18       Impact factor: 13.382

5.  Effects of naloxone-precipitated withdrawal after a single dose of morphine on catecholamine concentrations in guinea-pig brain.

Authors:  P J Brent; L A Chahl
Journal:  Neurochem Res       Date:  1991-05       Impact factor: 3.996

6.  The biological, social and clinical bases of drug addiction: commentary and debate.

Authors:  J Altman; B J Everitt; S Glautier; A Markou; D Nutt; R Oretti; G D Phillips; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.